We proposed that eating disorder psychopathology is maintained by a largely common set of mechanisms, and that treatments capable of addressing these mechanisms should be effective across the various eating disorder presentations.
The obvious next research step is to compare CBT-E with the leading other approach for adolescents, family-based treatment, and to do so across the full range of eating disorder presentations.
Both included the majority of those who were suitable and willing to be treated as outpatients, and they comprised patients with bulimia nervosa, binge eating disorder, the many and varied unspecified eating disorder presentations (Fairburn et al., 2007), and less underweight cases of anorexia nervosa (BMI > 17.5).
The aim of the present study was to evaluate the effects of CBT-E in a cohort of adolescents who were not underweight (i.e., those with bulimia nervosa, binge eating disorder or one of the other non-underweight eating disorder presentations).
There have been no studies of the treatment of binge eating disorder or the other eating disorder presentations yet they form the majority of cases (48 out of the 68 cases in the present cohort; 70.6%) (Ornstein et al., 2013; Smink, van Hoeken, Oldehinkel, & Hoek, 2014).
Although anxiety in ASD is present across the whole spectrum of the disorder, the presentation seems to be affected by individual factors, such as age, degree of social impairment and level of cognitive functioning [ 6].
Though I treat a lot of adults for attention-deficit hyperactivity disorder, the presentation of this case was a violation of an important diagnostic criterion: symptoms must date back to childhood.
Somatization disorder, the presentation of multiple somatic complaints in multiple organ systems, can be diagnosed by three roughly comparable diagnostic systems: the Washington University Feighner criteria, the Research Diagnostic Criteria, and DSM-III criteria.
Due to diagnostic instability in the early phases of the illness, and that an accurate diagnosis is on average delayed for 7.5 years in people with bipolar disorder, any presentation of FEM will be considered in this study (Ghaemi et al. 1999; Schimmelmann et al. 2005).
Using the statistical approach described above, two-thirds of the participants in both studies were in remission by the end of treatment, despite an average duration of eating disorder at presentation of 8.1 years in the original study (Fairburn et al., 2009) and 8.4 years in the present one.
